|
US5674908A
(en)
|
1993-12-20 |
1997-10-07 |
Life Technologies, Inc. |
Highly packed polycationic ammonium, sulfonium and phosphonium lipids
|
|
US6989434B1
(en)
|
1994-02-11 |
2006-01-24 |
Invitrogen Corporation |
Reagents for intracellular delivery of macromolecules
|
|
AU738384B2
(en)
*
|
1996-11-04 |
2001-09-20 |
Qiagen Gmbh |
Cationic reagents for transfection
|
|
CA2350882C
(en)
|
1998-11-12 |
2011-02-22 |
Life Technologies Corporation |
Transfection reagents
|
|
US7683035B1
(en)
|
1999-02-23 |
2010-03-23 |
Qiagen, Gmbh |
Method of stabilizing and/or isolating nucleic acids
|
|
US20030096414A1
(en)
|
2001-03-27 |
2003-05-22 |
Invitrogen Corporation |
Culture medium for cell growth and transfection
|
|
US7906122B2
(en)
|
2003-06-18 |
2011-03-15 |
Yissum Research Development Company Of The Hebrew University Of Jersusalem |
Sphingoid polyalkylamine conjugates for Hepatitis B virus vaccination
|
|
JP2006527763A
(ja)
*
|
2003-06-18 |
2006-12-07 |
イッスム・リサーチ・ディベロップメント・カンパニー・オブ・ザ・ヘブルー・ユニバーシティ・オブ・エルサレム |
スフィンゴ脂質のポリアルキルアミン抱合体
|
|
US20060211004A1
(en)
|
2005-02-15 |
2006-09-21 |
Ilsley Diane D |
Methods and compositions for determining non-specific cytotoxicity of a transfection agent
|
|
WO2006110358A2
(en)
*
|
2005-04-01 |
2006-10-19 |
Invitrogen Corporation |
Methods and compositions for introducing biopolymers into cells
|
|
EP2366787B1
(en)
|
2006-01-13 |
2019-12-11 |
The Government Of The U.S.A, As Represented By The Secretary, Dept. Of Health And Human Services |
Codon optimized IL-15 and IL-15R-Alpha genes for expression in mammalian cells
|
|
EP3434259A1
(en)
|
2007-05-04 |
2019-01-30 |
Marina Biotech, Inc. |
Amino acid lipids and uses thereof
|
|
US20110212021A1
(en)
|
2008-05-30 |
2011-09-01 |
Slack Frank J |
Targeted oligonucleotide compositions for modifying gene expression
|
|
CN104382853A
(zh)
|
2008-10-16 |
2015-03-04 |
玛瑞纳生物技术有限公司 |
基因沉默治疗剂的脂质体有效递送方法和组合物
|
|
SI2506857T1
(en)
|
2009-12-01 |
2018-08-31 |
Translate Bio, Inc. |
Delivery of mRNA for the enrichment of proteins and enzymes in human genetic diseases
|
|
WO2011106705A2
(en)
|
2010-02-26 |
2011-09-01 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Dna-protein vaccination protocols
|
|
WO2011120023A1
(en)
|
2010-03-26 |
2011-09-29 |
Marina Biotech, Inc. |
Nucleic acid compounds for inhibiting survivin gene expression uses thereof
|
|
WO2011133584A2
(en)
|
2010-04-19 |
2011-10-27 |
Marina Biotech, Inc. |
Nucleic acid compounds for inhibiting hras gene expression and uses thereof
|
|
WO2011139842A2
(en)
|
2010-04-28 |
2011-11-10 |
Marina Biotech, Inc. |
Nucleic acid compounds for inhibiting fgfr3 gene expression and uses thereof
|
|
FR2964569B1
(fr)
|
2010-09-10 |
2012-10-19 |
Ct De Cooperation Internationale En Rech Agronomique Pour Le Dev Cirad |
Nouveaux liposomes de vaccination genique
|
|
US8853377B2
(en)
|
2010-11-30 |
2014-10-07 |
Shire Human Genetic Therapies, Inc. |
mRNA for use in treatment of human genetic diseases
|
|
EP2648706A4
(en)
|
2010-12-06 |
2014-07-23 |
Penn State Res Found |
COMPOSITIONS AND METHODS RELATING TO PROLIFERATIVE DISEASES
|
|
KR20220025112A
(ko)
|
2011-06-08 |
2022-03-03 |
샤이어 휴먼 지네틱 테라피즈 인크. |
Mrna 전달을 위한 지질 나노입자 조성물 및 방법
|
|
ES2567091T3
(es)
|
2012-04-05 |
2016-04-19 |
F. Hoffmann-La Roche Ag |
Compuestos de amina para la preparación selectiva de muestras biológicas
|
|
EP3536787A1
(en)
|
2012-06-08 |
2019-09-11 |
Translate Bio, Inc. |
Nuclease resistant polynucleotides and uses thereof
|
|
EA201591229A1
(ru)
|
2013-03-14 |
2016-01-29 |
Шир Хьюман Дженетик Терапис, Инк. |
Способы очистки матричной рнк
|
|
KR102311614B1
(ko)
|
2013-03-14 |
2021-10-08 |
샤이어 휴먼 지네틱 테라피즈 인크. |
Cftr mrna 조성물 및 관련 방법 및 사용
|
|
CA2905649A1
(en)
|
2013-03-15 |
2014-09-18 |
The Penn State Research Foundation |
Compositions and methods including celecoxib and plumbagin relating to treatment of cancer
|
|
EP2968216A1
(en)
|
2013-03-15 |
2016-01-20 |
The Penn State Research Foundation |
Compositions and methods including leelamine and arachidonyl trifluoromethyl ketone relating to treatment of cancer
|
|
EP3574923A1
(en)
|
2013-10-22 |
2019-12-04 |
Translate Bio, Inc. |
Mrna therapy for phenylketonuria
|
|
ES2707966T3
(es)
|
2013-10-22 |
2019-04-08 |
Translate Bio Inc |
Terapia de ARNm para la deficiencia en síntesis de argininosuccinato
|
|
EP4729528A3
(en)
|
2014-04-25 |
2026-06-24 |
Translate Bio, Inc. |
Methods for purification of messenger rna
|
|
US10195280B2
(en)
|
2014-07-15 |
2019-02-05 |
Life Technologies Corporation |
Compositions and methods for efficient delivery of molecules to cells
|
|
MX2019010155A
(es)
|
2017-02-27 |
2020-12-10 |
Translate Bio Inc |
Arnm de cftr optimizado por codón novedoso.
|
|
IL270631B2
(en)
|
2017-05-16 |
2024-03-01 |
Translate Bio Inc |
Treatment of cystic fibrosis by delivery of codon-optimized mrna encoding cftr
|
|
US11174500B2
(en)
|
2018-08-24 |
2021-11-16 |
Translate Bio, Inc. |
Methods for purification of messenger RNA
|
|
AU2019384557B2
(en)
|
2018-11-21 |
2025-07-17 |
Translate Bio, Inc. |
Treatment of cystic fibrosis by delivery of nebulized mRNA encoding CFTR
|
|
US20220175723A1
(en)
|
2019-04-22 |
2022-06-09 |
The Penn State Research Foundation |
Methods and compositions relating to inhibition of aldehyde dehydrogenases for treatment of cancer
|
|
CA3155003A1
(en)
|
2019-09-20 |
2021-03-25 |
Translate Bio, Inc. |
Mrna encoding engineered cftr
|
|
US12616678B2
(en)
|
2020-06-10 |
2026-05-05 |
The Penn State Research Foundation |
Methods to of aldehyde dehydrogenases for treatment of cancer
|
|
CN114656422B
(zh)
*
|
2022-04-22 |
2023-05-23 |
重庆理工大学 |
一种新型氮杂冠醚化合物及其阳离子脂质体、制备方法与应用
|
|
CN119301272A
(zh)
|
2022-06-02 |
2025-01-10 |
瑞孚迪健康科学公司 |
腺相关病毒衣壳的dna含量的电泳介导的表征
|